Predictors of functional and clinical outcome in early-onset first-episode psychosis: The child and adolescent first episode of psychosis (CAFEPS) study

Journal of Clinical Psychiatry

Volumn 76, Issue 11, 2015, Pages e1441-e1448

  Parellada, Mara ^a   Castro Fornieles, Josefina ^b   Gonzalez Pinto, Ana ^c   Pina Camacho, Laura ^a,d   Moreno, Dolores ^a   Rapado Castro, Marta ^a   Otero, Soraya ^e   De La Serna, Elena ^c   Moreno, Carmen ^a   Baeza, Inmaculada ^b   Graell, Montserrat ^f   Arango, Celso ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILDREN GLOBAL ASSESSMENT SCALE; COHORT ANALYSIS; CONTROLLED STUDY; DSM-IV; FEMALE; FUNCTIONAL ASSESSMENT; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROIMAGING; NEUROLOGIC DISEASE ASSESSMENT; ONSET AGE; OXIDATIVE STRESS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; STRAUSS CARPENTER OUTCOME SCALE; EARLY DIAGNOSIS; EARLY INTERVENTION; FOLLOW UP; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; PRODROMAL SYMPTOM; PROGNOSIS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; TIME;

ADOLESCENT; AGE OF ONSET; CHILD; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PRODROMAL SYMPTOMS; PROGNOSIS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84958281025     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08863     Document Type: Article

References (58)

1. Chang WC, Tang JY, Hui CL, et al. Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study. Aust N Z J Psychiatry. 2012;46(2):100-108. doi:10.17/0486741428015 PubMed
2. Zipursky RB, Reilly TJ, Murray RM. The myth of schizophrenia as a progressive brain disease. Schizophr Bull. 2013;39(6):1363-1372. doi:10.1093/schbul/sbs135 PubMed
3. Langeveld J, Joa I, Friis S, et al. A comparison of adolescent-and adult-onset first-episode, nonaffective psychosis: 2-year follow-up. Eur Arch Psychiatry Clin Neurosci. 2012;262(7):599-605. doi:10.107/s0406-012-0308-9 PubMed
4. Schimmelmann BG, Conus P, Cotton S, et al. Pre-treatment, baseline, and outcome differences between early-onset and adultonset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res. 2007;95(1-3):1-8. doi:10.1016/j.schres.207.06.04 PubMed
5. Amminger GP, Henry LP, Harrigan SM, et al. Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study. Schizophr Res. 2011;131(1-3):112-119. doi:10.1016/j.schres.201.06.09 PubMed
6. Castro-Fornieles J, Baeza I, de la Serna E, et al. Two-year diagnostic stability in early-onset first-episode psychosis. J Child Psychol Psychiatry. 2011;52(10):1089-1098. doi:10.1/j.1469-7610.201.0243.x PubMed
7. Malla A, Norman R, Schmitz N, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med. 2006;36(5):649-658. doi:10.1017/S0329170607379 PubMed
8. Möller HJ, Jäger M, Riedel M, et al. The Munich 15-year follow-up study (MUFUSSAD) on firsthospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci. 2010;260(5):367-384. doi:10.107/s0406-010-017-y PubMed
9. Spellmann I, Riedel M, Schennach R, et al. Oneyear functional outcomes of naturalistically treated patients with schizophrenia. Psychiatry Res. 2012;198(3):378-385. doi:10.1016/j.psychres.201.12.047 PubMed
10. Jeppesen P, Petersen L, Thorup A, et al. The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychol Med. 2008;38(8):1157-1166. doi:10.1017/S032917080349 PubMed
11. Alvarez-Jimenez M, Priede A, Hetrick SE, et al. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res. 2012;139(1-3):116-128. doi:10.1016/j.schres.2012.05.07 PubMed
12. Juola P, Miettunen J, Veijola J, et al. Predictors of short-and long-term clinical outcome in schizophrenic psychosis-the Northern Finland 1966 Birth Cohort study. Eur Psychiatry. 2013;28(5):263-268. PubMed
13. Nuechterlein KH, Subotnik KL, Green MF, et al. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011;37(suppl 2):S33-S40. doi:10.1093/schbul/sbr084 PubMed
14. O'Connor JA, Wiffen B, Diforti M, et al. Neuropsychological, clinical and cognitive insight predictors of outcome in a first episode psychosis study. Schizophr Res. 2013;149(1-3):70-76. doi:10.1016/j.schres.2013.06.05 PubMed
15. Chang WC, Tang JY, Hui CL, et al. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res. 2013;209(3):353-360. doi:10.1016/j.psychres.2013.02.014 PubMed
16. Ayesa-Arriola R, Rodríguez-Sánchez JM, Pérez-Iglesias R, et al. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with firstepisode psychosis: a 3 year longitudinal study. Psychiatry Res. 2013;209(3):302-308. doi:10.1016/j.psychres.2013.01.024 PubMed
17. Strauss GP, Allen DN, Miski P, et al. Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia. Schizophr Res. 2012;135(1-3):134-138. doi:10.1016/j.schres.201.1.07 PubMed
18. Arango C, Rapado-Castro M, Reig S, et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012;69(1):16-26. doi:10.101/archgenpsychiatry.201.150 PubMed
19. Mechelli A, Riecher-Rössler A, Meisenzahl EM, et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry. 2011;68(5):489-495. doi:10.101/archgenpsychiatry.201.42 PubMed
20. Parellada M, Moreno C, Mac-Dowell K, et al. Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res. 2012;46(3):394-401. doi:10.1016/j.jpsychires.201.10.04 PubMed
21. Emiliani FE, Sedlak TW, Sawa A. Oxidative stress and schizophrenia: recent breakthroughs from an old story. Curr Opin Psychiatry. 2014;27(3):185-190. doi:10.1097/YCO.054 PubMed
22. Parellada M, Moreno C, Moreno M, et al. Placebo effect in child and adolescent psychiatric trials. Eur Neuropsychopharmacol. 2012;22(11):787-799. PubMed
23. Bakker SC, Hoogendoorn ML, Selten JP, et al. Neuregulin 1: genetic support for schizophrenia subtypes. Mol Psychiatry. 2004;9(12):1061-1063. doi:10.1038/sj.mp.401564 PubMed
24. Castro-Fornieles J, Parellada M, Gonzalez-Pinto A, et al; CAFEPS group. The child and adolescent first-episode psychosis study (CAFEPS): design and baseline results. Schizophr Res. 2007;91(1-3):226-237. doi:10.1016/j.schres.206.12.04 PubMed
25. Reig S, Parellada M, Castro-Fornieles J, et al. Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis. Schizophr Bull. 2011;37(6):1270-1280. doi:10.1093/schbul/sbq04 PubMed
26. Shaffer D, Gould MS, Brasic J, et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231. doi:10.101/archpsyc.1983.017901074010 PubMed
27. Peralta V, Cuesta MJ. Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiatry Res. 1994;53(1):31-40. doi:10.1016/0165-1781(94)9093-0 PubMed
28. Kirkpatrick B, Buchanan RW, Breier A, et al. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res. 1993;47(1):47-56. doi:10.1016/0165-1781(93)9054-K PubMed
29. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and Lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988. doi:10.1097/04583-197070-021 PubMed
30. Guy W. ECDEU: Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
31. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470-484. doi:10.1093/schbul/8.3.470 PubMed
32. Amador XF, Strauss DH, Yale SA, et al. Assessment of insight in psychosis. Am J Psychiatry. 1993;150(6):873-879. doi:10.176/ajp.150.6.873 PubMed
33. Strauss JS, Carpenter WT Jr. The prediction of outcome in schizophrenia: I. characteristics of outcome. Arch Gen Psychiatry. 1972;27(6):739-746. doi:10.101/archpsyc.1972.0175030102 PubMed
34. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989;27(3):335-350. doi:10.1016/0165-1781(89)90148-0 PubMed
35. Lewis SW, Owen MJ, Murray RM. Obstetric complications and schizophrenia: methodology and mechanisms. In: Schulz SC, Tamminga CA, eds. Schizophrenia: A Scientific Focus. New York, NY: Oxford University Press; 1989.
36. Bombin I, Mayoral M, Castro-Fornieles J, et al. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychol Med. 2013;43(4):757-768. PubMed
37. Zabala A, Rapado M, Arango C, et al. Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups. Eur Arch Psychiatry Clin Neurosci. 2010;260(3):225-233. doi:10.107/s0406-09-046-9 PubMed
38. Sattler J, Ryan J. Wechsler Adult Intelligence Scale-III: Description. In: Sattler J, ed. Assessment of Children: Cognitive Applications. 4th ed. San Diego, CA: Jerome M. Sattler; 2001:409-411.
39. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. 2007;165(1):1-13. doi:10.1093/aje/kwj347 PubMed
40. Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ. 2006;174(3):341-348. doi:10.1503/cmaj.05074 PubMed
41. Singh SM, Murphy B, O'Reilly RL. Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia. Clin Genet. 2003;64(6):451-460. doi:10.1046/j.139-04.203.0190.x PubMed
42. Micó JA, Rojas-Corrales MO, Gibert-Rahola J, et al. Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry. 2011;11(1):26. doi:10.186/1471-24X-1-26 PubMed
43. Kates WR, Warsofsky IS, Patwardhan A, et al. Automated Talairach atlas-based parcellation and measurement of cerebral lobes in children. Psychiatry Res. 1999;91(1):11-30. doi:10.1016/S0925-4927(9)01-6 PubMed
44. Desco M, Pascau J, Reig S, et al. Multimodality Image Quantification Using Talairach Grid. Paper Presented at Proceedings of SPIE Medical Imaging. 2001; San Diego, CA: SPIE;4422:1385-1392
45. Reig S, Moreno C, Moreno D, et al. Progression of brain volume changes in adolescent-onset psychosis. Schizophr Bull. 2009;35(1):233-243. doi:10.1093/schbul/sbm160 PubMed
46. Ho BC, Andreasen NC, Flaum M, et al. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry. 2000;157(5):808-815. doi:10.176/api.ajp.157.5.808 PubMed
47. Hollis C. Developmental precursors of child-and adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. Br J Psychiatry. 2003;182(1):37-44. doi:10.192/bjp.182.1.37 PubMed
48. Iyer SN, Mangala R, Thara R, et al. Preliminary findings from a study of first-episode psychosis in Montreal, Canada and Chennai, India: comparison of outcomes. Schizophr Res. 2010;121(1-3):227-233. doi:10.1016/j.schres.2010.05.032 PubMed
49. Fraguas D, de Castro MJ, Medina O, et al. Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev. 2008;39(2):137-145. doi:10.107/s10578-07-076-3 PubMed
50. Galderisi S, Mucci A, Bitter I, et al; Eufest Study Group. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. Eur Neuropsychopharmacol. 2013;23(3):196-204. PubMed
51. Antonius D, Prudent V, Rebani Y, et al. White matter integrity and lack of insight in schizophrenia and schizoaffective disorder. Schizophr Res. 2011;128(1-3):76-82. doi:10.1016/j.schres.201.02.020 PubMed
52. Karlsgodt KH, Niendam TA, Bearden CE, et al. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry. 2009;66(6):562-569. doi:10.1016/j.biopsych.209.03.013 PubMed
53. Zhang XY, Zhou DF, Qi LY, et al. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. Psychopharmacology (Berl). 2009;204(1):177-184. doi:10.107/s0213-08-147-6 PubMed
54. Tosato S, Ruggeri M, Bonetto C, et al. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(5):647-659. doi:10.102/ajmg.b.30484 PubMed
55. Patiño-Garcia A, Santos JL, Paya B, et al. The genetic contribution to first psychotic episodes in children and adolescents of the child and adolescent first-episode psychosis study. Psychiatr Genet. 2008;18(3):151-152. doi:10.1097/YPG.0b013e3282f97e2d PubMed
56. Werry JS, McClellan JM, Andrews LK, et al. Clinical features and outcome of child and adolescent schizophrenia. Schizophr Bull. 1994;20(4):619-630. doi:10.1093/schbul/20.4.619 PubMed
57. McGorry PD, Nelson B, Amminger GP, et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009;70(9):1206-1212. doi:10.408/JCP.08r0472 PubMed
58. Hegelstad WT, Larsen TK, Auestad B, et al. Longterm follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. Am J Psychiatry. 2012;169(4):374-380.